Sponsored borrowers get restricted-payment capacity at 45% of EBITDA. Founder-owned borrowers get 28%.

Why do lenders price the presence of a sponsor?

Because a sponsor is a second source of capital that is already committed to the outcome, and a lender is underwriting the downside rather than the plan. When a credit deteriorates, a sponsored borrower has an institutional equity holder with a fund behind it, a reputation with that lender across other transactions, and a rational incentive to protect a position rather than hand over keys. A founder-owned borrower has a founder, whose remaining capital is usually in the business already.

The regulatory evidence supports the underwriting rather than merely the folklore. Private-equity-sponsored borrowers correlate positively with the use of payment-in-kind features, and yet are less likely to progress from delinquency to outright default, because sponsors can inject liquidity (Financial Stability Board, Report on Vulnerabilities in Private Credit, 6 May 2026). Sponsored credits go wrong at least as often. They resolve differently.

That asymmetry is worth stating precisely, because it is frequently misquoted as sponsored borrowers being better credits. They are not necessarily better credits. They have a better-capitalized owner, which is a different property, and it is the property the lender is pricing.

The behavioural evidence points the same way at the point of maturity. Private-equity-backed borrowers drove 74% of maturity-extension amendments in the market to 30 June 2026 (PitchBook LCD, through 30 June 2026). When the extension conversation happens, sponsored borrowers are disproportionately the ones having it.

What is actually published, and what is not?

The number every founder-owned borrower wants is the spread premium, and it is not available on a dated basis. A 75 to 150 basis point non-sponsored premium circulates widely and we have been able to verify the content of it, but not to date the page carrying it. An undated figure cannot be presented as current market evidence, so we do not present it.

The dated substitute is the size ladder, which is measuring something adjacent and is measured properly. At identical seniority, unitranche prices at S+550 to 750 for a borrower below $10m of EBITDA and S+425 to 575 for a borrower above $25m, a gap of roughly 125 to 175 basis points (SPP Capital Partners, Market At A Glance, July 2026). On a $20m facility that is $250,000 to $350,000 a year for nothing other than being larger and better packaged.

That matters here because size and sponsorship are correlated in this market without being the same thing. Most sub-$10m EBITDA borrowers are founder-owned, and most sponsored credits sit above that band, so a founder-owned borrower comparing itself to a published sponsored print is usually comparing across both variables at once and attributing the whole gap to the wrong one.

Two further pieces of context are worth holding. Sponsored pricing has itself deteriorated from the lender's point of view: the share of lenders seeing top-tier sponsor spreads at S+4.75% or tighter fell from 86% to 41% over the year to the second quarter of 2026 (Houlihan Lokey, Q2 2026 Private Credit Survey). And covenant relief remains a large-borrower product: covenant-lite structures are 21% of direct lending deals, up from 4% in 2023, with 91% of those above $50m of EBITDA (Proskauer via ABF Journal, June 2026). The gap between sponsored and founder-owned is real; the gap between large and small is wider and better evidenced.

Where does the gap show up in the documents?

In flexibility rather than in price, which is where a founder-owned borrower least expects to find it. The one clean sponsored against non-sponsored differential available for 2026 is capacity: general restricted-payments basket capacity ran 45% of EBITDA for sponsored deals against 28% for non-sponsored in the first half of the year (9fin, US Covenant Trends Report H1 2026).

Restricted payments capacity is what allows cash to leave the credit group, for a dividend, an owner distribution, a payment to an affiliate or an investment outside the perimeter. A founder-owned business, where the owner's personal finances and the company's are usually more entangled than a sponsor's are, receives materially less of it. That is the opposite of what the situation calls for, and it is rarely on the negotiation list.

The protective terms have moved the other way, which is a rare piece of good news for the non-sponsored side. Blockers against the liability-management structures that reallocate collateral away from existing lenders are near-standard in sponsored leveraged loans, and in non-sponsored high yield one common form doubled from 14% in 2025 to 27% in the first half of 2026 (9fin, H1 2026). Non-sponsored documents are catching up on the terms that protect a lender against the borrower's other creditors.

The structural expectations differ too, and they are stated openly. Lenders require a minimum 40% base equity capitalization with at least 60% of that in new cash, and independent sponsors are expected to demonstrate investment beyond rolled deal fees (SPP Capital Partners, July 2026). A founder rolling equity into a transaction should expect that same test applied to what the roll actually represents in cash terms.

Who actually lends to a founder-owned business?

Increasingly, the same institutions that lend to sponsored ones, plus a bank market that has come back for relationship credit. Direct lenders still finance roughly 90% of buyout transactions below $500m of enterprise value (ABF Journal, 19 March 2026), and individual bank hold sizes in middle-market leveraged lending have contracted from $75m to $100m down to $30m to $50m, with several large regionals having exited the segment entirely since 2024.

That is the structural retreat, and it is specific to leveraged lending. It is not a general bank retreat, and treating it as one leads a founder-owned borrower to skip the cheaper market. In the July 2026 senior loan officer survey, the net percentage of domestic banks tightening standards on commercial and industrial loans was 0.0% for large and middle-market firms and 1.8% for small firms, down from 8.1% and 6.6% in April, with banks reporting basically unchanged standards and easing or unchanged terms across the board (Federal Reserve, July 2026 Senior Loan Officer Opinion Survey, published 3 August 2026).

They are also competing on price. A net 26.8% of banks narrowed spreads over cost of funds to large and middle-market firms, and a net 14.5% to small firms, the widest net narrowing in the recent series. Bank commercial and industrial loans reached $2,894.2bn in June 2026, up 8.0% year over year after being flat through 2025 (Federal Reserve H.8). Across eleven super-regional banks, commercial and industrial lending was the largest source of commercial loan growth in the second quarter, with several citing winning share back from private credit (Trepp via GlobeSt, 3 August 2026).

There is also new capacity specifically aimed at the smaller, often founder-owned end. Thirty-six new Small Business Investment Company licences were issued in the 2026 fiscal year to date, twenty-five of them at the highest leverage tier (Small Business Administration Office of Investment and Innovation, Federal Register notices through 7 July 2026), and legislation signed in May 2026 raised leverage caps and exempted rural, manufacturing and critical-technology investments from the cap (SBA News Release 26-53, 21 May 2026). This is the part of the market most likely to be structurally better supplied in 2027 than it is now.

What closes part of the gap?

Supplying the things a sponsor supplies, which is more achievable than it sounds because most of them are informational rather than financial. A lender pricing a sponsored credit is buying monthly reporting it trusts, a board that meets, a downside case it did not have to build itself, and a counterparty that has been through this before. Each of those can be produced by a founder-owned business that decides to.

The one that moves pricing most is the downside case. A borrower who arrives with a modelled downside, a stated set of actions at each trigger point and a covenant headroom analysis against its own numbers is answering the question the credit committee is going to ask anyway. A borrower who arrives with a base case alone leaves the committee to build the downside, and committees build conservative ones.

The second is a stated second source of capital. It does not have to be a fund. Undrawn shareholder capacity, a documented family commitment, a subordinated facility from an existing relationship, or a minority equity partner already in diligence all partly answer the question that the sponsor otherwise answers.

The third is competition, which is the only lever that reliably moves price. Half of all firms obtain only two quotes before choosing a lender, and the dispersion in what firms pay does not appear to be explained by risk (Amiti, Kashyap, Kovner and Weinstein, NBER Working Paper 34870, February 2026). A founder-owned borrower running a genuine process against four or five lenders is correcting for the single largest documented pricing inefficiency in the market, and it costs nothing but time.

What none of this closes is the second cheque. A founder-owned borrower should expect to pay something for its absence, expect the number to be unpublished, and expect the terms differential to sit in basket capacity and flexibility rather than in the coupon it was watching.